- Home
- SELF vs TIL Comparison
SELF vs TIL Comparison
Compare SELF & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | TIL |
|---|---|---|
| Founded | 1983 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.0M | 54.8M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SELF | TIL |
|---|---|---|
| Price | $5.22 | $7.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $6.00 | ★ $125.00 |
| AVG Volume (30 Days) | 15.0K | ★ 15.4K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | ★ 6.06 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $12,705,245.00 | N/A |
| Revenue This Year | $3.04 | N/A |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | $131.25 | ★ N/A |
| Revenue Growth | ★ 1.40 | N/A |
| 52 Week Low | $4.73 | $5.67 |
| 52 Week High | $5.63 | $33.83 |
Technical Indicators
Market Signals| Indicator | SELF | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 48.98 | 44.66 |
| Support Level | $4.96 | $7.59 |
| Resistance Level | $5.27 | $8.30 |
| Average True Range (ATR) | 0.11 | 0.30 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 53.57 | 46.57 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.